![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-a0e9d1a18432c29f6b1f5442b03cacb3dc2ca564bedfe71cd432dfff6c8181d2.jpg)
Phosphodiesterase Type 5 Inhibitors for Penile Rehabilitation Post Radical Prostatectomy: A Review of Clinical Effectiveness and Guidelines
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.